Clinical Trials · NCT01989780

Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer

Name: Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Gonadorelin

Phase: Phase 2
Recruitment status: Completed
Sponsor: Japan Breast Cancer Research Group
Enrollment: 160
Start date: Jan 2014
Locations: 1 site, Japan
Primary endpoint: Time to failure of strategy (TFS)

View Gonadorelin compound reference